Financhill
Sell
15

BDRX Quote, Financials, Valuation and Earnings

Last price:
$1.58
Seasonality move :
-18.41%
Day range:
$1.56 - $1.75
52-week range:
$1.56 - $74.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.43x
P/B ratio:
0.10x
Volume:
219.9K
Avg. volume:
2.4M
1-year change:
-93.51%
Market cap:
$1.1M
Revenue:
$474.1K
EPS (TTM):
-$74.60

Earnings Data

Next earnings date for BDRX
Apr 18
2025
Most recent earnings per share
--
Missed by --
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2019 Q2 -- -- -- -$208.17 --
03/31/2019 Q1 -- -- -- -$104.09 --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -$5,107.44 --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -$7,794.30 --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -$6,395.04 --
06/30/2017 Q2 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --

Biodexa Pharmaceuticals PLC Earnings Questions

  • How Much did Biodexa Pharmaceuticals PLC Generate in Revenue Last Quarter?

    Biodexa Pharmaceuticals PLC reported -- worth of top line sales in its most recent quarter.

  • Did Biodexa Pharmaceuticals PLC Beat Earnings Last Quarter?

    Biodexa Pharmaceuticals PLC announced earnings per share of -- which represents a miss of analyst forecast a -- per share.

  • Is Biodexa Pharmaceuticals PLC Profitable?

    Biodexa Pharmaceuticals PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Biodexa Pharmaceuticals PLC EPS Next Year?

    Biodexa Pharmaceuticals PLC's earnings are forecast to decrease from -$248.86 per share to -$0.06 per share next year representing a decrease of -99.98%.

  • When is Biodexa Pharmaceuticals PLC's Earnings Date?

    Biodexa Pharmaceuticals PLC's next earnings date is April 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Is Hindsight Bias In Investing?
What Is Hindsight Bias In Investing?

You’ve probably heard the expression “hindsight is 20/20.” That saying…

Is Rivian a Good Stock a Buy?
Is Rivian a Good Stock a Buy?

Rivian Automotive (RIVN) had an initial IPO of close to…

Will Chevron Acquire Hess?
Will Chevron Acquire Hess?

Long-time Buffett favorite in the energy sector Chevron (NYSE:CVX) is…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
47
RGC alert for Mar 26

Regencell Bioscience Holdings [RGC] is up 4.9% over the past day.

Sell
39
W alert for Mar 26

Wayfair [W] is up 2.01% over the past day.

Sell
46
TSLA alert for Mar 26

Tesla [TSLA] is up 3.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock